Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
1.
Front Oncol ; 14: 1283991, 2024.
Article in English | MEDLINE | ID: mdl-38884092

ABSTRACT

Objective: To explore the Therapeutic effect of synchronous Integrated intensity modulated radiotherapy combined with chemotherapy in stage IIIc of Cervical Cancer. Methods: A total of 58 patients with stage IIIC cervical cancer (KPS ≥ 80) were analyzed in this study. They were admitted to our hospital between August 2017 and August 2022. Synchronous integrated boost intensity-modulated radiotherapy (SIB-IMRT) and sequential boost intensity-modulated radiotherapy (LCB-IMRT) were used to treat pelvic and/or para-aortic metastatic lymph nodes, with 30 cases in the SIB group and 28 cases in the LCB group. Comparison of short-term and long-term efficacy. Comparison of recurrence and metastasis rates, radiation dose to organs at risk and incidence of adverse drug reactions. Result: 30 patients were treated with simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT), and 28 patients were treated with sequential boost intensity-modulated radiotherapy (LCB-IMRT). At the completion of radiotherapy and 3 months after radiotherapy, there was no significant difference in clinical efficacy observed between the two treatment groups. The median overall survival (OS), progression-free survival (PFS), and disease-free survival (DMR) in the SIB-IMRT group were significantly higher compared to the LCB-IMRT group. The SIB-IMRT group demonstrated significantly lower rates compared to the LCB-IMRT group. Furthermore, within 3 years and 5 years, the rates of lymph node recurrence, cervical and vaginal local recurrence, and distant metastasis within the radiotherapy field were significantly lower in the SIB-IMRT group compared to the LCB-IMRT group. There were no significant differences observed between the two groups in terms of the maximum dose to the small intestine (Dmax), dose received by 2cc of the small intestine (D2cc), maximum dose to the rectum (Dmax), and dose received by 1cc of the bladder (D1cc). The incidence of bone marrow toxicity in the SIB-IMRT group was significantly lower compared to the LCB-IMRT group. Moreover, the occurrence of grade III and IV bone marrow toxicity was also significantly lower in the SIB-IMRT group compared to the LCB-IMRT group. Conclusion: The study has concluded that there is no significant differences in in terms of bladder associated adverse events and gastrointestinal toxicity in both Simultaneous Integrated Boost Intensity-Modulated Radiotherapy and Layered Conical Beam Intensity-Modulated Radiation Therapy.

2.
Front Pediatr ; 11: 1116166, 2023.
Article in English | MEDLINE | ID: mdl-36937984

ABSTRACT

Background: Stevens-Johnson syndrome/toxic epidermal necrolysis has a severe impact on patients' eyes, genital mucosa, and many other organs. Bronchiolitis obliterans is a rare complication of Stevens-Johnson syndrome/toxic epidermal necrolysis. Data sources: We report a case of bronchiolitis obliterans associated with toxic epidermal necrolysis in our department. Furthermore, we examined the patients with bronchiolitis obliterans induced by Stevens-Johnson syndrome/toxic epidermal necrolysis and summarized the clinical characteristics, treatment, and prognosis. Databases available online in English including PubMed, Medline, and Web of Science were consulted. Results: We report one case and review 23 published case reports. Of the 24 patients, 13 were female, the oldest patient was 59 years old and the youngest was 5 years old. The time of bronchiolitis obliterans onset after Stevens-Johnson syndrome/toxic epidermal necrolysis varied from 5 days to 5 months. Bronchoscopy examination showed ulceration, exudative lesions, occlusion, and inflammation. The CT of lung manifestation included mosaic perfusion, bronchiectasis, consolidation, air trapping, pneumatocele, pleural thickening, lung collapse, larger central airway dilatation, lung overinflation, oligemia, and pneumomediastinum. Most cases indicated pulmonary function tests with obstructive ventilation dysfunction. The prognosis was poor; six of the patients died. Conclusions: Patients with Stevens-Johnson syndrome/toxic epidermal necrolysis may develop bronchitis obliterans at different stages, so all patients with Stevens-Johnson syndrome/toxic epidermal necrolysis should be followed up for possible respiratory complications.

4.
Comput Intell Neurosci ; 2022: 4390394, 2022.
Article in English | MEDLINE | ID: mdl-35761870

ABSTRACT

In this paper, we propose an assisted driving system implemented with a Jetson nano-high-performance embedded platform by using machine vision and deep learning technologies. The vehicle dynamics model is established under multiconditional assumptions, the path planner and path tracking controller are designed based on the model predictive control algorithm, and the local desired path is reasonably planned in combination with the behavioral decision system. The behavioral decision algorithm based on finite state machine reasonably transforms the driving state according to the environmental changes, realizes the following of the target vehicle speed, and can take effective emergency braking in time when there is a collision danger. The system can complete the motion planning by the model predictive control algorithm and control the autonomous vehicle to smoothly track the replanned local desired path to complete the lane change overtaking action, which can meet the demand of ADAS. The path planner is designed based on the MPC algorithm, solving the objective function with obstacle avoidance function, planning the optimal path that can avoid a collision, and using 5th order polynomial to fit the output local desired path points. In 5∼8 s time, the target vehicle decelerates to 48 km/h; the autonomous vehicle immediately makes a deceleration action and gradually reduces the speed difference between the two vehicles until it reaches the target speed, at which time the distance between the two vehicles is close to the safe distance, obtained by the simulation test results. The system can still accurately track the target when the vehicle is driving on a curve and timely control the desired speed change of the vehicle, and the target vehicle always maintains a safe distance. The system can be used within 50 meters.


Subject(s)
Artificial Intelligence , Automobile Driving , Accidents, Traffic/prevention & control , Computers , Technology
5.
BMC Pediatr ; 21(1): 398, 2021 09 13.
Article in English | MEDLINE | ID: mdl-34511063

ABSTRACT

BACKGROUND: Methylmalonic acidemia is an organic acid metabolism disorder that usually has nonspecific clinical manifestations. CASE PRESENTATION: A 3-month-old female infant was admitted to the hospital for developmental retardation. Her prenatal and birth history was unremarkable. After admission, she developed dyspnea and severe anemia and was subsequently transferred to the intensive care unit. Magnetic resonance imaging of her brain showed a Dandy-Walker malformation, and metabolic screening indicated methylmalonic acidemia. Thus, she was diagnosed with methylmalonic acidemia and Dandy-Walker malformation. The patient underwent treatment including acidosis correction, blood transfusion, antibiotics, mechanical ventilation and heat preservation. Unfortunately, her condition progressively worsened and she died of metabolic crisis. CONCLUSIONS: Dandy-Walker malformation may be a clinical manifestation of methylmalonic acidemia. Additionally, the co-existence of methylmalonic acidemia and Dandy-Walker malformation may be an uncharacterized syndrome which needs to be studied further.


Subject(s)
Amino Acid Metabolism, Inborn Errors , Dandy-Walker Syndrome , Amino Acid Metabolism, Inborn Errors/complications , Amino Acid Metabolism, Inborn Errors/diagnosis , Brain/diagnostic imaging , Dandy-Walker Syndrome/complications , Dandy-Walker Syndrome/diagnosis , Female , Humans , Infant , Magnetic Resonance Imaging , Pregnancy
6.
Int J Gen Med ; 14: 4025-4030, 2021.
Article in English | MEDLINE | ID: mdl-34349552

ABSTRACT

PURPOSE: Social support is increasingly recognized to be important in care of people living with HIV/AIDS (PLWH), we firstly translate and validate the disease-targeted social support instrument in Chinese and to explore the correlation with WHOQOL-HIV. PATIENTS AND METHODS: We established content validity for HIV-related social support scale (HSSS) and administered the resultant questionnaire to 310 PLWH. Descriptive statistics were generated for each of the variables of general characteristics; student t-test was used to compare the different groups. RESULTS: The HSSS demonstrated a high level of internal consistency, both within each subscale and with the total score; all Cronbach's α values exceeded a priori threshold of ≥0.70. The HSSS cores were positively correlated with WHOQOL-HIV total scores (Pearson correlation: 0.39, P < 0.001). We also found that higher educational level, personal income, CD4 cell count, and shorter duration of antiretroviral therapy are significantly associated with a higher level of social support (P < 0.05). CONCLUSION: Social support may improve quality of life for PLWH, Chinese version of HIV-related social support scale can be used in future clinical practice.

7.
Oncogene ; 40(36): 5468-5481, 2021 09.
Article in English | MEDLINE | ID: mdl-34290402

ABSTRACT

The ARID1A gene, which encodes a subunit of the SWI/SNF chromatin remodeling complex, has been found to be frequently mutated in many human cancer types. However, the function and mechanism of ARID1A in cancer metastasis are still unclear. Here, we show that knockdown of ARID1A increases the ability of breast cancer cells to proliferate, migrate, invade, and metastasize in vivo. The ARID1A-related SWI/SNF complex binds to the second exon of CDH1 and negatively modulates the expression of E-cadherin/CDH1 by recruiting the transcriptional repressor ZEB2 to the CDH1 promoter and excluding the presence of RNA polymerase II. The silencing of CDH1 attenuated the migration, invasion, and metastasis of breast cancer cells in which ARID1A was silenced. ARID1A depletion increased the intracellular enzymatic processing of E-cadherin and the production of C-terminal fragment 2 (CTF2) of E-cadherin, which stabilized ß-catenin by competing for binding to the phosphorylation and degradation complex of ß-catenin. The matrix metalloproteinase inhibitor GM6001 inhibited the production of CTF2. In zebrafish and nude mice, ARID1A silencing or CTF2 overexpression activated ß-catenin signaling and promoted migration/invasion and metastasis of cancer cells in vivo. The inhibitors GM6001, BB94, and ICG-001 suppressed the migration and invasion of cancer cells with ARID1A-deficiency. Our findings provide novel insights into the mechanism of ARID1A metastasis and offer a scientific basis for targeted therapy of ARID1A-deficient cancer cells.


Subject(s)
Antigens, CD , Cadherins , Animals , Humans , Mice
8.
Materials (Basel) ; 14(11)2021 May 27.
Article in English | MEDLINE | ID: mdl-34071932

ABSTRACT

In this paper, we report a novel anCd simple method for synthesizing the microspheres self-assembled from ultrathin anatase TiO2 nanosheets with a high percentage of (001) facets via the hydrolysis process of the single-reagent (potassium fluorotitanate). We then used optical microscopy, scanning electron microscopy, and high-resolution confocal laser Raman spectroscopy to characterize the microspheres generated under different conditions. The study found that the size of the anatase TiO2 microspheres synthesized was 0.5-3 µm. As the synthesis time increased, the corroded surface of the microspheres gradually increased, resulting in the gradual disappearance of the edges and corners of the anatase nanosheets. The exposure percentage of the (001) facets of ultrathin anatase nanosheets synthesized for 2 h at 180-200 °C are close to 100%. The microsphere whose surface is completely covered by these anatase nanosheets also has nearly 100% exposed (001) facets. This new anatase nanosheet-based self-assembled microsphere will have great application potential in pollution prevention, environmental protection, and energy fields.

9.
BMC Endocr Disord ; 21(1): 110, 2021 May 27.
Article in English | MEDLINE | ID: mdl-34044824

ABSTRACT

BACKGROUND: Children with diabetic ketoacidosis often have elevated lactate. In this study, we investigated the clinical variables associated with hyperlactatemia in children with diabetic ketoacidosis. METHODS: We designed a single-center retrospective descriptive study of children with diabetic ketoacidosis in a pediatric intensive care unit. RESULTS: Of the 107 patients with diabetic ketoacidosis included in the analysis, 61 developed hyperlactatemia. Multivariate logistic regression analysis showed that heart rate (p = 0.003),diastolic blood pressure (p = 0.001) and stage of severity (p = 0.042) were independently associated with the development of hyperlactatemia in diabetic ketoacidosis. We found that lactate level was not significantly associated with length of hospital stay (p = 0.115) or the length of time to diabetic ketoacidosis resolution (p = 0.143). CONCLUSIONS: Children with diabetic ketoacidosis presenting with severer stage, elevated heart rate and higher diastolic blood pressure may be prone to hyperlactatemia. Hyperlactatemia was not associated with length of time to DKA resolution and length of hospital stay.


Subject(s)
Biomarkers/blood , Diabetic Ketoacidosis/complications , Hyperlactatemia/pathology , Intensive Care Units, Pediatric/statistics & numerical data , Lactic Acid/blood , Length of Stay/trends , Severity of Illness Index , Child , Female , Follow-Up Studies , Humans , Hyperlactatemia/blood , Hyperlactatemia/etiology , Male , Prognosis , Retrospective Studies
10.
Pediatr Rheumatol Online J ; 18(1): 90, 2020 Nov 17.
Article in English | MEDLINE | ID: mdl-33203428

ABSTRACT

BACKGROUND: Systemic lupus erythematosus (SLE) is an autoimmune disease involving multiple systems with various clinical manifestations. Renal involvement is common, but intracardiac thrombus is rarely reported as a complication of antiphospholipid syndrome (APS, also known as anticardiolipin syndrome). Anticoagulant therapy is the first-line treatment, and surgery is performed in severe cases. We report a case to improve clinicians' understanding of disease diagnosis. CASE PRESENTATION: An 8-year-old girl was admitted to our hospital because of left costal pain, hematuria and fever. She had obvious edema occult blood 3+, urinary protein 3.2 g/24 h, albumin 17.6 g/L, and total cholesterol 7.21 mmol/L, consistent with a diagnosis of nephrotic syndrome. We continued to track the etiology of nephrotic syndrome and performed a renal biopsy, showing dsDNA 1:10 positivity, low C3, low platelets and hemoglobin, anticardiolipin IgM 12 U/ml, anti-ß2-glycoprotein I (ß2GPI) 223 U/ml; renal pathology suggested lupus nephritis (LN), and the patient was ultimately diagnosed with SLE, secondary APS and LN. The patient was treated with hormones and immunosuppressants. Sixteen weeks later, her urinary protein was 1+, and the quantity of urine protein was less than 0.5 g/d. Echocardiography showed that the mass in the right atrium was thrombotic. Heparin anticoagulant therapy was effective. CONCLUSION: SLE can involve multiple systems and various complications. Thrombus in the right atrium is a rare complication of APS. Early diagnosis and treatment are key to improving the prognosis of children.


Subject(s)
Heart Atria/diagnostic imaging , Heart Diseases , Heparin/administration & dosage , Immunosuppressive Agents/administration & dosage , Lupus Erythematosus, Systemic , Thrombosis/diagnostic imaging , Anticoagulants/administration & dosage , Antiphospholipid Syndrome/complications , Antiphospholipid Syndrome/immunology , Child , Female , Heart Diseases/diagnosis , Heart Diseases/etiology , Heart Diseases/physiopathology , Heart Diseases/therapy , Humans , Immunologic Tests/methods , Kidney/pathology , Lupus Erythematosus, Systemic/blood , Lupus Erythematosus, Systemic/physiopathology , Lupus Erythematosus, Systemic/therapy , Nephrotic Syndrome/diagnosis , Nephrotic Syndrome/etiology , Nephrotic Syndrome/physiopathology , Treatment Outcome
11.
Drug Des Devel Ther ; 14: 4451-4463, 2020.
Article in English | MEDLINE | ID: mdl-33122889

ABSTRACT

PURPOSE: Glucocorticoids are used for the treatment of inflammatory diseases, but glucocorticoid treatment is associated with bone damage. Resveratrol is a phytoalexin found in many plants, and we investigated its protective role on dexamethasone-induced dysfunction in MC3T3-E1 cells and primary osteoblasts. MATERIALS AND METHODS: MC3T3-E1 cells and primary osteoblasts were treated with dexamethasone in the presence/absence of different doses of resveratrol for 24 or 48 h. Then, 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium (MTT) and lactate dehydrogenase (LDH) assays were used to evaluate cell viability. Apoptosis was analyzed by a flow cytometry. An alkaline phosphatase (ALP) activity assay and Alizarin Red S staining were used to study osteoblast differentiation. Expression of osteoblast-related genes was measured by real-time reverse transcription-quantitative polymerase chain reaction (RT-qPCR). The AMP-activated protein kinase (AMPK) signaling pathway and mitochondrial expression of superoxide dismutase were evaluated by Western blotting. Intracellular reactive oxygen species (ROS), adenosine triphosphate (ATP) content, mitochondrial-complex activity, and mitochondrial DNA content were measured to evaluate mitochondrial function. RESULTS: Resveratrol induced the proliferation and inhibited apoptosis of osteoblasts in the presence of dexamethasone. Resveratrol increased the ALP activity and mineralization of osteoblasts. Resveratrol also attenuated dexamethasone-induced inhibition of mRNA expression of osteogenesis maker genes, including bone morphogenetic protein-2, osteoprotegerin, runt-related transcription factor-2, and bone Gla protein. Resveratrol alleviated dexamethasone-induced mitochondrial dysfunction. Resveratrol strongly stimulated expression of peroxisome proliferator-activated receptor-γ coactivator 1α and sirtuin-3 genes, as well as their downstream target gene superoxide dismutase-2. Resveratrol induced phosphorylation of AMPK and acetyl-CoA carboxylase (ACC). Blockade of AMPK signaling using compound C reversed the protective effects of resveratrol against dexamethasone. CONCLUSION: Resveratrol showed protective effects against dexamethasone-induced dysfunction of osteoblasts by activating AMPK signaling.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Dexamethasone/antagonists & inhibitors , Osteoblasts/drug effects , Protective Agents/pharmacology , Resveratrol/pharmacology , Animals , Cell Survival/drug effects , Cells, Cultured , Dexamethasone/pharmacology , Dose-Response Relationship, Drug , Male , Mice , Mice, Inbred C57BL , Molecular Structure , Osteoblasts/metabolism , Phosphorylation/drug effects , Structure-Activity Relationship
12.
Mar Pollut Bull ; 135: 311-317, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30301043

ABSTRACT

Proteome response of plants is an important process that enables them to cope with environmental stress including metal stress. In this study, the proteome of Gracilaria lemaneiformis exposed to lead was investigated. Two-dimensional gel electrophoresis analysis revealed 123 protein spots, among which 14 proteins were significantly differentially expressed and identified using MALDI-TOF MS. Two of the up-regulated proteins were identified and predicted to be involved in photosynthesis and signal transduction, while eleven down-regulated proteins were functionally grouped into five classes including photosynthesis, energy metabolism, protein metabolism, carbohydrate transport and metabolism, and antioxidation proteins. There was also an up-regulation in superoxide dismutase, peroxidase, glutathione s-transferase, and heat-shock protein 70 upon Pb exposure. Proteomic studies provide a better picture of protein networks and metabolic pathways primarily involved in intracellular detoxification and defense mechanisms.


Subject(s)
Gracilaria/chemistry , Gracilaria/drug effects , Lead/pharmacology , Proteome/metabolism , Electrophoresis, Gel, Two-Dimensional , Glutathione Transferase/chemistry , Glutathione Transferase/genetics , Glutathione Transferase/metabolism , Gracilaria/genetics , Gracilaria/metabolism , Photosynthesis , Plant Leaves/chemistry , Plant Leaves/drug effects , Plant Leaves/genetics , Plant Leaves/metabolism , Plant Proteins/chemistry , Plant Proteins/genetics , Plant Proteins/metabolism , Proteome/chemistry , Proteome/genetics , Proteomics , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Stress, Physiological
13.
Int J Nanomedicine ; 12: 8599-8613, 2017.
Article in English | MEDLINE | ID: mdl-29238194

ABSTRACT

Efficient and safe nonviral gene delivery systems are a prerequisite for the clinical application of therapeutic genes. In this paper, polyethyleneimine-capped silver nanoclusters (PEI-AgNCs) were prepared for the purpose of microRNA (miRNA) delivery. The resultant PEI-AgNCs were characterized by a photoluminescence assay and transmission electron microscopy. A cytotoxicity assay showed that PEI-AgNCs exhibit relatively low cytotoxicity. Interestingly, PEI-AgNCs were confirmed to transfect miRNA mimics more effectively than PEI in HepG2 and 293A cells. In this regard, hsa-miR-21 or hsa-miR-221 mimics (miR-21/221m) were transported into HepG2 cells by using PEI-AgNCs. The miR-21/221 expression was determined post-transfection by quantitative real-time polymerase chain reaction. Compared with the negative control, PEI-AgNCs/miR-21/221m groups exhibited higher miR-21/221 levels. In addition, AgNCs endow PEI with stronger antibacterial activity, and this advantage provided PEI-AgNCs the potential to prevent bacterial contamination during the transfection process. Furthermore, we showed that PEI-AgNCs are viable nanomaterials for plain imaging of the cells by laser scanning confocal microscopy, indicating great potential as an ideal fluorescent probe to track the transfection behavior. These results demonstrated that PEI-AgNCs are promising and novel nonviral vectors for gene delivery.


Subject(s)
MicroRNAs/administration & dosage , Nanostructures/chemistry , Polyethyleneimine/chemistry , Silver/administration & dosage , Transfection/methods , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/pharmacology , Escherichia coli/drug effects , HEK293 Cells , Hep G2 Cells , Humans , MicroRNAs/genetics , Microscopy, Confocal , Nanostructures/administration & dosage , Oligonucleotides/administration & dosage , Polyethyleneimine/pharmacology , Real-Time Polymerase Chain Reaction , Silver/chemistry
14.
Gene ; 627: 194-201, 2017 Sep 05.
Article in English | MEDLINE | ID: mdl-28627440

ABSTRACT

Abnormal activation of hepatic gluconeogenesis is a major contributor to fasting hyperglycemia in type 2 diabetes; however, the potential role of microRNAs in gluconeogenesis remains unclear. Here, we showed that hepatic expression levels of microRNA-21 (miR-21) were decreased in db/db and high-fat diet (HFD)-induced diabetic mice. Adenovirus-mediated overexpression of miR-21 decreased the expression of phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase) and inhibited glucose production in primary mouse hepatocytes. Silencing of miR-21 reversed this effect. Overexpression of miR-21 in the livers of db/db and HFD-induced mice was able to suppress hepatic gluconeogenesis, subsequently decreasing blood glucose levels and improving glucose and insulin intolerance. Furthermore, overexpression of miR-21 in primary mouse hepatocytes and mouse livers decreased the protein levels of FOXO1 and increased hepatic insulin sensitivity. By contrast, silencing of miR-21 increased the protein levels of FOXO1, subsequently leading to a decrease in insulin sensitivity and impaired glucose intolerance in C57BL/6 mice fed with high-fat diet for 4weeks. Finally, we confirmed that FOXO1 was a potential target of miR-21. These results suggest that miR-21 is a critical regulator in hepatic gluconeogenesis and may provide a novel therapeutic target for treating insulin resistance and type 2 diabetes.


Subject(s)
Diabetes Mellitus, Type 2/genetics , Forkhead Box Protein O1/metabolism , Gluconeogenesis , Glucose/metabolism , Liver/metabolism , MicroRNAs/genetics , Animals , Cells, Cultured , Diabetes Mellitus, Type 2/metabolism , Forkhead Box Protein O1/genetics , Hepatocytes/metabolism , Male , Mice , Mice, Inbred C57BL , MicroRNAs/metabolism
15.
Case Rep Orthop ; 2017: 7439016, 2017.
Article in English | MEDLINE | ID: mdl-28203471

ABSTRACT

The objective was to report a case of a 63-year-old man with a history of low back pain (LBP) and left leg pain for 2 years, and the symptom became more serious in the past 5 months. The patient was diagnosed with lumbar scoliosis combined with lumbar spinal stenosis (LSS) and lumbar disc herniation (LDH) at the level of L4-5 that was confirmed using Computerized Topography and Magnetic Resonance Imaging. The surgical team preformed a novel technique, "U" route transforaminal percutaneous endoscopic lumbar discectomy (PELD), which led to substantial, long-term success in reduction of pain intensity and disability. After removing the osteophyte mass posterior to the thecal sac at L4-5, the working channel direction was changed to the gap between posterior longitudinal ligament and thecal sac, and we also removed the herniation and osteophyte at L3-4 with "U" route PELD. The patient's symptoms were improved immediately after the surgical intervention; low back pain intensity decreased from preoperative 9 to postoperative 2 on a visual analog scale (VAS) recorded at 1 month postoperatively. The success of the intervention suggests that "U" route PELD may be a feasible alternative to treat lumbar scoliosis with LSS and LDH patients.

16.
Oncotarget ; 7(29): 46127-46141, 2016 Jul 19.
Article in English | MEDLINE | ID: mdl-27323812

ABSTRACT

The tumor suppressor gene AT-rich interactive domain-containing protein 1A (ARID1A) was frequently mutated in cancers. The modulation mechanism of ARID1A for PI3K/AKT signaling in gastric cancer (GC) remains elusive. Here, we found that depletion of endogenous ARID1A enhanced the in vitro proliferation, colony formation, cellular growth, nutrient uptake and in vivo xenograft tumor growth of GC cells. PI3K/AKT activation by ARID1A-silencing was profiled using a phospho-protein antibody array. The phosphorylation of PDK1, AKT, GSK3ß and 70S6K, and the protein and mRNA expressions of PI3K and PDK1, were upregulated by ARID1A-silencing. Chromatin immunoprecipitation and luciferase reporter assay revealed that ARID1A-involved SWI/SNF complex inhibited PIK3CA and PDK1 transcription by direct binding to their promoters. Serial deletion mutation analyses revealed that the ARID1A central region containing the HIC1-binding domain, but not the ARID DNA-binding domain and the C-terminal domain, was essential for the inhibition of GC cell growth, PI3K/AKT pathway phosphorylation and its transcriptional modulation activity of PIK3CA and PDK1. The proliferation, cellular growth and glucose consumption of ARID1A-deficient GC cells were efficiently prohibited by allosteric inhibitors mk2206 and LY294002, which targeting AKT and PI3K, respectively. Both inhibitors also downregulated the phosphorylation of PI3K/AKT pathway in ARID1A-deficient GC cells. Such cells were sensitized to the treatment of LY294002, and AT7867, another inhibitor of AKT and p70S6K. The administration of LY294002 alone inhibited the in vivo growth of ARID1A- deficient GC cells in mouse xenograft model. Our study provides a novel insight into the modulatory function and mechanism of ARID1A in PI3K/AKT signaling in GC.


Subject(s)
Class I Phosphatidylinositol 3-Kinases/metabolism , Gene Expression Regulation, Neoplastic/physiology , Nuclear Proteins/metabolism , Protein Serine-Threonine Kinases/metabolism , Stomach Neoplasms/pathology , Transcription Factors/metabolism , Animals , Cell Line, Tumor , Cell Proliferation/physiology , DNA-Binding Proteins , Heterografts , Humans , Mice , Mice, Nude , Pyruvate Dehydrogenase Acetyl-Transferring Kinase , Signal Transduction/physiology , Stomach Neoplasms/metabolism
17.
Hepatology ; 63(3): 880-97, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26659654

ABSTRACT

UNLABELLED: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death. However, the underlying mechanism during hepatocarcinogenesis remains unclarified. Stable isotope labeling by amino acids in cell culture (SILAC) is a powerful quantitative strategy for proteome-wide discovery of novel biomarkers in cancers. Hippocalcin-like 1 (HPCAL1) is a calcium sensor protein. However, the biological function of HPCAL1 is poorly understood in cancers, including HCC. Herein, HPCAL1 was identified by SILAC as a novel hepatocarcinogenesis suppressor down-regulated in HCC cell lines and tissues. Importantly, lost expression of HPCAL1 was associated with worse prognosis of HCC patients. Interestingly, secreted HPCAL1 protein in the plasma dropped dramatically in HCC patients compared with healthy donors. Receiver operating characteristic curve analysis showed that serum HPCAL1 at a concentration of 8.654 ng/mL could better predict HCC. Furthermore, ectopic expression of HPCAL1 suppresses cell proliferation, while depletion of HPCAL1 led to increased cell growth both in vitro and in vivo. Mechanistically, HPCAL1 directly interacted with p21(Waf/Cip1) in the nucleus, which requires the EF-hand 4 motif of HPCAL1 and the Cy1 domain of p21. This interaction stabilized p21(Waf/Cip1) in an extracellular signal-regulated kinase 1/2-mitogen-activated protein kinase-dependent manner, which subsequently prevented p21(Waf/Cip1) proteasomal degradation by disrupting SCF(Skp2) and CRL4(Cdt2) E3 ligase complexes, resulting in increased protein stability and inhibitory effect of p21(Waf/Cip1). Notably, the tumor suppressive function of HPCAL1 was dependent on p21 in vitro and in vivo. Consistent with this observation, expression of HPCAL1 and p21(Waf/Cip1) was positively correlated in HCC tissues. CONCLUSION: These findings highlight a novel tumor suppressor upstream of p21(Waf/Cip1) in attenuating cell cycle progression and provide a promising diagnostic and prognostic factor, as well as a potential therapeutic target for HCC.


Subject(s)
Carcinoma, Hepatocellular/metabolism , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Liver Neoplasms/metabolism , Neurocalcin/metabolism , Animals , Case-Control Studies , Cell Cycle , Cell Line, Tumor , HEK293 Cells , Humans , Isotope Labeling/methods , MAP Kinase Signaling System , Male , Mice, Inbred BALB C , Mice, Nude , Neoplasm Transplantation , Nuclear Proteins/metabolism , Proteomics/methods , S-Phase Kinase-Associated Proteins/metabolism , Ubiquitin-Protein Ligases/metabolism
18.
Oncotarget ; 6(36): 39088-97, 2015 Nov 17.
Article in English | MEDLINE | ID: mdl-26384299

ABSTRACT

Loss of the tumor suppressor gene AT-rich interactive domain-containing protein 1A (ARID1A) has been demonstrated in several cancers, but its prognostic role is unknown. We aimed to investigate the risk associated with loss of ARID1A (ARID1A-) for all-cause mortality, cancer-specific mortality and recurrence of disease in subjects with cancer. PubMed and SCOPUS search from database inception until 01/31/2015 without language restriction was conducted, contacting authors for unpublished data. Eligible were prospective studies reporting data on prognostic parameters in subjects with cancer, comparing participants with presence of ARID1A (ARID1A+) vs. ARID1A-, assessed either via immunohistochemistry (loss of expression) or with genetic testing (presence of mutation). Data were summarized using risk ratios (RR) for number of deaths/recurrences and hazard ratios (HR) for time-dependent risk related to ARID1A- adjusted for potential confounders. Of 136 hits, 25 studies with 5,651 participants (28 cohorts; ARID1A-: n = 1,701; ARID1A+: n = 3,950), with a mean follow-up period of 4.7 ± 1.8 years, were meta-analyzed. Compared to ARID1A+, ARID1A- significantly increased cancer-specific mortality (studies = 3; RR = 1.55, 95% confidence interval (CI) = 1.19-2.00, I(2) = 31%). Using HRs adjusted for potential confounders, ARID1A- was associated with a greater risk of cancer-specific mortality (studies = 2; HR = 2.55, 95%CI = 1.19-5.45, I(2) = 19%) and cancer recurrence (studies = 10; HR = 1.93, 95%CI = 1.22-3.05, I(2) = 76%). On the basis of these results, we have demonstrated that loss of ARID1A shortened time to cancer-specific mortality, and to recurrence of cancer when adjusting for potential confounders. For its role, this gene should be considered as an important potential target for personalized medicine in cancer treatment.


Subject(s)
Genes, Tumor Suppressor , Nuclear Proteins/genetics , Transcription Factors/genetics , Cohort Studies , DNA-Binding Proteins , Female , Humans , Male , Middle Aged , Mutation , Neoplasms/genetics , Prognosis
19.
J Proteomics ; 110: 155-71, 2014 Oct 14.
Article in English | MEDLINE | ID: mdl-25118038

ABSTRACT

Stromal microenvironment influences tumor cell proliferation and migration. Fibroblasts represent the most abundant stromal constituents. Here, we established two pairs of normal fibroblast (NF) and cancer-associated fibroblast (CAF) cultures from colorectal adenocarcinoma tissues and the normal counterparts. The NFs and CAFs were stained positive for typical fibroblast markers and inhibited colon cancer (CC) cell proliferation in in vitro cocultures and in xenograft mouse models. The fibroblast conditioned media were analyzed using LC-MS and 227 proteins were identified at a false discovery rate of 1.3%, including 131 putative secretory and 20 plasma membrane proteins. These proteins were enriched for functional categories of extracellular matrix, adhesion, cell motion, inflammatory response, redox homeostasis and peptidase inhibitor. Secreted protein acidic and rich in cysteine, transgelin, follistatin-related protein 1 (FSTL1) and decorin was abundant in the fibroblast secretome as confirmed by Western blot. Silencing of FSTL1 and transgelin in colonic fibroblast cell line CCD-18Co induced an accelerated proliferation of CC cells in cocultures. Exogenous FSTL1 attenuates CC cell proliferation in a negative fashion. FSTL1 was upregulated in CC patient plasma and cancerous tissues but had no implication in prognosis. Our results provided novel insights into the molecular signatures and modulatory role of CC associated fibroblasts. BIOLOGICAL SIGNIFICANCE: In this study, a label-free LC-MS was performed to analyze the secretomes of two paired primary fibroblasts, which were isolated from fresh surgical specimen of colorectal adenocarcinoma and adjacent normal colonic tissues and exhibited negative modulatory activity for colon cancer cell growth in in vitro cocultures and in vivo xenograph mouse models. Follistatin-related protein 1 was further revealed to be one of the stroma-derived factors of potential suppression role for colon cancer cell proliferation. Our results provide novel insights into the molecular signatures and the modulatory role of colon cancer associated fibroblasts, and establish a valuable resource for the development of therapeutic agents or novel clinic biomarker.


Subject(s)
Colon/metabolism , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/pathology , Fibroblasts/metabolism , Metabolome , Neoplasm Proteins/metabolism , Proteome/metabolism , Cell Proliferation , Colon/pathology , Fibroblasts/pathology , Neoplasm Invasiveness , Neoplasm Proteins/chemistry , Proteome/chemistry , Tumor Cells, Cultured , Tumor Microenvironment
20.
Data Brief ; 1: 19-24, 2014 Dec.
Article in English | MEDLINE | ID: mdl-26217680

ABSTRACT

The tumor cell proliferation, migration and invasion were influenced by the interaction between the cancer cells and their microenvironment. In current study, we established two pairs of the primary fibroblast cultures from colorectal adenocarcinoma tissues and the normal counterparts and identified 227 proteins in the colonic fibroblast secretomes; half of these proteins were novel. The mass spectrometry data and analyzed results presented here provide novel insights into the molecular characteristics and modulatory role of colon cancer associated fibroblasts. The data is related to "Identification of colonic fibroblast secretomes reveals secretory factors regulating colon cancer cell proliferation" by Chen et al. [1].

SELECTION OF CITATIONS
SEARCH DETAIL
...